Discussing HER2- Positive Breast Cancer With a Patient Advocate

摘要

At an Around the Practice presentation hosted by CancerNetwork?, multi-disciplinary oncology clinicians and a patient advocate discussed treatment options for managing HER2-positive breast cancer and explored the treatment journey from the perspective of a patient. The panel was led by Sara Hurvitz, MD, medical director of the University of California Los Angeles (UCLA) Jonsson Comprehensive Cancer Center Clinical Research Unit, co-director of the Santa Monica-UCLA Outpatient Oncology Practices, and director of UCLA's Breast Cancer Clinical Trials Program. Other experts were Kamran Ahmed, MD, chief of radiation oncology at Moffitt Cancer Center in Tampa, Florida, and Julia LaBarbera, NP, a nurse practitioner of oncology at UCLA in Santa Monica, California.They were joined by Erika Rich of Pittsburgh, Pennsylvania, a patient advocate and survivor of HER2-positive breast cancer.